VIV:CC News and Press, Avivagen Inc. From 03/16/23

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health ...

- New approvals for sales in multiple countries - Raised more than $8.5 million in equity and debt financings - Revenues of approximately $1 million - Succession plan implemented to support next phase of accelerated growth Avivagen Inc. (TSXV:VIV) (“Avivag...

-Publication showcases the cumulative understanding to-date of Avivagen’s product from both a scientific and real world application perspective -Product’s value and safety has been shown through use in many settings, under differing conditions and in millions of animals ...

Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting...

Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby ...

**Not for Distribution to United States News Wire Services or for Dissemination in the United States.** Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing p...

**NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.** Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing p...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...

Publication of this Scientific Paper on the Safety of Oxidized Beta Carotene is a milestone on the path to broader regulatory clearance to market and sell OxC-beta ™ Products in the U.S. and supports wide-spread adoption of the technology around the world ...

*Family-owned dairy business with established reputation for high-quality products turning to OxC-beta™ to support quality of milk * Order procured through Meyenberg International, Avivagen’s Mexican distribution partner Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) ...